|
|
||||||||
1 Department of Pharmacology, University of Vermont, Colchester, Vermont 05446; and 2 Department of Physiology and The Medical Biotechnology Center, University of Maryland School of Medicine, Baltimore, Maryland 21201
| |
ABSTRACT |
|---|
|
|
|---|
Forskolin, which elevates cAMP levels, and sodium nitroprusside
(SNP) and nicorandil, which elevate cGMP levels, increased, by two- to
threefold, the frequency of subcellular
Ca2+ release
("Ca2+ sparks") through
ryanodine-sensitive Ca2+ release
(RyR) channels in the sarcoplasmic reticulum (SR) of myocytes isolated
from cerebral and coronary arteries of rats. Forskolin, SNP,
nicorandil, dibutyryl-cAMP, and adenosine increased the frequency of
Ca2+-sensitive
K+
(KCa) currents
["spontaneous transient outward currents" (STOCs)] by
two- to threefold, consistent with
Ca2+ sparks activating STOCs.
These agents also increased the mean amplitude of STOCs by 1.3-fold, an
effect that could be explained by activation of
KCa channels, independent of
effects on Ca2+ sparks. To test
the hypothesis that cAMP could act to dilate arteries through
activation of the Ca2+
spark
KCa channel pathway,
the effects of blockers of KCa
channels (iberiotoxin) and of Ca2+
sparks (ryanodine) on forskolin-induced dilations of pressurized cerebral arteries were examined. Forskolin-induced dilations were partially inhibited by iberiotoxin and ryanodine (with no additive effects) and were entirely prevented by elevating external
K+. Forskolin lowered average
Ca2+ in pressurized arteries while
increasing ryanodine-sensitive, caffeine-induced
Ca2+ transients. These experiments
suggest a new mechanism for cyclic nucleotide-mediated dilations
through an increase in Ca2+ spark
frequency, caused by effects on SR
Ca2+ load and possibly on the RyR
channel, which leads to increased STOC frequency, membrane potential
hyperpolarization, closure of voltage-dependent
Ca2+ channels, decrease in
arterial wall Ca2+, and,
ultimately, vasodilation.
cAMP; cGMP; vasodilation; sarcoplasmic reticulum; KCa channels
| |
INTRODUCTION |
|---|
|
|
|---|
LOCAL CALCIUM TRANSIENTS or "Ca2+ sparks" have recently been measured in smooth muscle cells from cerebral arteries (28). Ca2+ sparks in arterial myocytes as well as in cardiac myocytes (6) appear to arise from the opening of one or the coordinated opening of several tightly clustered ryanodine-sensitive Ca2+ release (RyR) channels in the sarcoplasmic reticulum (SR). In arterial myocytes, Ca2+ sparks activate 10-100 nearby sarcolemmal Ca2+-sensitive K+ (KCa) channels to cause an outward K+ current (17, 28), previously referred to as a "spontaneous transient outward current" (STOC) (4). Ca2+ sparks, themselves, contribute little to overall cellular Ca2+ in pressurized cerebral arteries, since their activity is asynchronous (~1/s in a cerebral artery myocyte) (28). Ca2+ spark-activated KCa channels can continuously regulate, as a negative feedback element, the membrane potential of smooth muscle cells in intact pressurized cerebral arteries (7). Thus either blocking Ca2+ sparks or decreasing their frequency of occurrence (5) would lead to membrane potential depolarization and vasoconstriction through a decrease in KCa channel activity (Ref. 28; see also Refs. 7 and 31). Therefore, these results predict that increasing Ca2+ spark frequency could lead to vasodilation through activation of KCa channels.
The cyclic nucleotides, cAMP and cGMP, mediate vasodilation of
important endogenous and therapeutic agents (e.g.,
-adrenergic agents, adenosine, calcitonin gene-related peptide, nitric oxide, atrial natriuretic factor, synthetic nitrovasodilators). Diverse mechanisms have been proposed to explain the vasodilator effect of
cyclic nucleotides, including the stimulation of
Ca2+ uptake by the SR (24), the
direct activation of KCa channels (39), activation of ATP-sensitive
K+ channels (18, 19, 36, 48),
activation of voltage-dependent K+
channels (1), and changes in the
Ca2+ sensitivity of the
contractile process (11, 15, 41). Relaxation of cerebral and coronary
arteries to agents that elevate cAMP or cGMP are inhibited by blockers
of KCa channels (29, 32, 33, 35,
42, 47). In fact, in a number of other types of smooth muscle (airway,
mesenteric, uterine, pulmonary), blockers of
KCa channels (iberiotoxin or
charybdotoxin) reduce significantly the relaxing effects of agents that
elevate cAMP and cGMP (2, 3, 8, 16, 23).
KCa channels can be activated by
cAMP-dependent protein kinase (PKA) and cGMP-dependent protein kinase
(PKG) (39, 44). Recent evidence suggests that
KCa channels in pressurized arteries with tone are primarily activated by local
Ca2+ transients, i.e.,
Ca2+ sparks, and not directly by
average intracellular Ca2+ (28).
We therefore explored the possibility that cAMP and cGMP can increase
KCa channel activity by affecting
Ca2+ sparks. Specifically, our
results provide direct evidence that cAMP and cGMP increase the
frequency of local Ca2+ release
events (Ca2+ sparks) from the SR,
which activate KCa channels.
Furthermore, we provide evidence that cAMP can act, in part, to dilate
pressurized arteries through the
Ca2+ spark
KCa channel pathway.
| |
METHODS |
|---|
|
|
|---|
Cell isolation. Single smooth muscle cells were enzymatically isolated from cerebral (basilar) and coronary (septal) arteries of rats. The cell isolation procedure was slightly modified from that previously described for cerebral (37) and coronary (38) arteries. Briefly, an artery was dissected out and placed in ice-cold Ca2+-free isolation solution of the following composition (in mM): 60 NaCl, 85 sodium glutamate, 5.6 KCl, 2 MgCl2, 10 glucose, and 10 HEPES (pH 7.4). After 10 min, the artery was transferred to the first of two enzyme solutions, with the same ionic composition as the Ca2+-free isolation solution described above, containing 1 mg/ml albumin, 0.5 mg/ml papain (Worthington, Freehold, NJ), and 1 mg/ml dithioerythritol, and was digested for 25 min at 37°C. The tissue was then transferred into isolation solution containing 0.1 mM CaCl2 and 1 mg/ml of a collagenase mixture of 30% type H + 70% type F (Sigma) and was digested for another 10 min at 37°C. The tissue was then washed twice in Ca2+-free fresh isolation solution without enzymes for 10 min. Single smooth muscle cells were obtained from the digested artery by gentle trituration with a polished wide-bore pipette. After trituration, cells were stored in the same solution at 4°C, to be used the same day. Cells were left to stick to the coverslip in the experimental chamber for 15-20 min.
Ca2+ spark measurements. The procedure for the measurement of sparks is described in Ref. 28. Briefly, the cells were loaded with the Ca2+-sensitive indicator fluo 3 by a 20-min incubation in 5 µM fluo 3-AM and 2.5 µg/ml pluronic acid (Molecular Probes, Eugene, OR) followed by a 20-min wash. All measurements were made within 30 min of the end of the wash. The cells were scanned with a Bio-Rad 1000 laser scanning confocal microscope, which was housed in the University of Vermont Cell Imaging Facility. The resolution was 0.4 µm × 0.4 µm (x and y) × 0.8 µm (z) (28). Images were acquired using the line scan mode of the confocal microscope; this mode repeatedly scans a single line through a cell. A scan duration of 6 ms was used. Cells were positioned so that the line would traverse the long axis of the cell to detect sparks occurring in as much of the cell volume as possible. The average length of the cell through which the scan line passed was 36 µm. Scan lines are displayed vertically, and each line is added to the right of the preceding line to form the line scan image. In these images, time passes in the horizontal direction running from left to right, and position along the scan line is given by the vertical displacement. To minimize the possibility of laser damage affecting the Ca2+ handling of the cells, control and test measurements were made from different cells, with each cell being scanned for the same duration, 18 s total (6 consecutive line scan images of 512 lines, at 6 ms/line, were recorded from each cell along a single line). Sparks were analyzed using custom-written (IDL, Research Systems, Boulder, CO) analysis programs. To test the significance in the changes of Ca2+ spark frequency, a one-way ANOVA on ranks (Student-Newman-Keuls) method was used.
Electrophysiological recordings. K+ currents were measured in the whole cell, perforated-patch configuration (14) of the patch-clamp technique (13) with the use of an Axopatch 200A amplifier (Axon Instruments, Foster City, CA). The bathing solution (also used for spark measurements) contained (in mM) 134 NaCl, 6 KCl, 1 MgCl2, 2 CaCl2, 10 glucose, and 10 HEPES (pH 7.4). The pipette solution contained (in mM) 110 potassium aspartate, 30 KCl, 10 NaCl, 1 MgCl2, 10 HEPES, and 0.05 EGTA. All experiments were conducted at room temperature (23°C). Membrane currents were recorded, while holding the cells at membrane potentials of
40 mV, or as indicated. The STOCs were analyzed off-line,
with the use of custom analysis programs. Briefly, STOCs were
identified by setting a current threshold at three times the mean
KCa single-channel amplitude at
40 mV (~5 pA), and all events that were greater than this
threshold were included. The mean amplitude and frequency of the STOCs
were determined. The large amplitude and low open probability
(Po) of the
KCa channel permitted the
measurement of single KCa channel
currents with the use of the perforated-patch configuration of the
whole cell voltage clamp. To observe single KCa channel currents,
Ca2+ sparks and hence STOCs were
prevented by thapsigargin (28), which inhibits the SR
Ca2+-ATPase, and the cells were
clamped at 0 mV.
NPo was
calculated over 5-min intervals as
Nj=1 tj · j/T,
where tj is the
time spent with j = 1, 2, . . . N channels open,
N is the maximum number of channels
observed, and T is the duration of the
recording (5 min).
Intact pressurized artery.
Resistance-sized posterior-cerebral arteries from rats were isolated,
cannulated, and pressurized to 60 mmHg as described in Refs. 7, 31, and
20. The maximal diameter of the pressurized arteries was estimated from
the arterial diameter in 30 µM diltiazem. Arterial diameter was
measured with a video dimension analyzer (Living Systems
Instrumentations, Burlington, VT). Results are expressed as means (in
µm) ± SE for n vessels in
diameter experiments. Student's
t-test was used to compare values. A
value of P < 0.05 was considered
significant.
Conventional Ca2+ imaging. Isolated smooth muscle cells and intact arteries were loaded with the Ca2+ indicator dye fura 2. Cells were incubated with 0.25 µM fura 2-AM for 15 min. Cells were then washed and allowed to sit for 20 min before measurements were made. Arteries were loaded by incubation with 2 µM fura 2-AM for 45 min. Arteries were then cannulated and continuously superfused with physiological salt solution at 37°C. Ca2+ was measured ratiometrically (340:380 nm) using the IMAGE-1/FL quantitative fluorescence measurement program (Universal Imaging, West Chester, PA).
Chemicals. Unless otherwise stated, all chemicals used in this study were obtained from Sigma Chemical (St. Louis, MO), including the following drugs: forskolin, adenosine, dibutyryl-cAMP (DBcAMP), sodium nitroprusside (SNP), thapsigargin, and diltiazem. H-89 and ryanodine were obtained from Calbiochem (La Jolla, CA), and iberiotoxin was from Peptides International (Louisville, KY). Nicorandil was a gift from Chugai Pharmaceuticals (Tokyo, Japan).| |
RESULTS |
|---|
|
|
|---|
Forskolin, SNP, and nicorandil increase Ca2+ spark frequency. To test the hypothesis that increases in cAMP and cGMP can increase the frequency of Ca2+ sparks, the effects of forskolin (an activator of adenylyl cyclase that elevates cAMP), SNP, and nicorandil (nitric oxide donors, which elevate cGMP) on Ca2+ sparks were examined in single smooth muscle cells isolated from rat cerebral and coronary arteries. Forskolin significantly increased (P < 0.05) the Ca2+ spark frequency 2.3-fold (Fig. 1, A and B), as measured with a laser scanning confocal microscope and the Ca2+ fluorescence indicator fluo 3. This increase was prevented by an inhibitor of PKA, H-89 (1 µM), which binds to the active center of the catalytic subunit and suppresses the kinase activity (Fig. 1, A and B). The nitrovasodilators, SNP and nicorandil, also increased Ca2+ spark frequency 2.2- and 2.6-fold, respectively (Fig. 1C; P < 0.05). Forskolin, H-89, or SNP did not cause statistically significant changes in Ca2+ spark amplitude or rate of decay. Nicorandil did, however, cause a small but significant increase in Ca2+ spark amplitude (8% increase). If, indeed, Ca2+ sparks can activate sarcolemmal KCa channels, then forskolin, SNP, and nicorandil should increase the frequency of STOCs in these preparations, as had been suggested to occur in other preparations (9, 22).
|
40 mV, a potential similar to that of intact pressurized cerebral arteries (7, 20, 31). Whole cell currents were measured using
the perforated-patch mode of the whole cell configuration, so as not to
disturb the intracellular contents of the cells. Forskolin increased
STOC frequency by 2.8 ± 0.5-fold (from 0.9 ± 0.2 Hz;
n = 9; Figs.
2 and
3A). The
PKA inhibitor H-89 (1 µM) completely reversed the effect of forskolin
(Figs. 2 and 3A). Forskolin caused a
small but significant (P < 0.05)
increase in the average STOC amplitude by 1.3 ± 0.1-fold, which was
also reversed by H-89 (Figs. 2 and
3B). Neither forskolin nor H-89
affected the decay of the STOCs. Forskolin had no effect on STOC
frequency or amplitude in the continued presence of H-89. The
nitrovasodilators, SNP (10 µM) and nicorandil (100 µM), also
increased STOC frequencies (SNP, 4.0 ± 1.5-fold,
n = 4; nicorandil, 3.3 ± 0.8-fold,
n = 8) and amplitudes (SNP, 1.2 ± 0.1-fold, n = 4; nicorandil, 1.3 ± 0.1-fold, n = 8). These results are
consistent with the idea that forskolin, through cAMP, and SNP and
nicorandil, through cGMP, can increase
Ca2+ spark and STOC frequency by
200-300% and STOC amplitude by ~30%.
|
|
Forskolin increases the NPo of KCa channels in the absence of Ca2+ sparks. The forskolin-induced increase in Ca2+ spark frequency would explain the observed elevation of STOC frequency. However, the effect of forskolin on STOC amplitude cannot be explained by its action on Ca2+ sparks alone, because the amplitude of the spark was unaffected. A possible explanation for the 1.3-fold increase in STOC amplitude to forskolin is through an elevation of open state probability (Po) of KCa channels caused by PKA phosphorylation of the channel, as has been demonstrated in excised patches by others (23). An elevated Po of KCa channels would lead to higher Po of the KCa channels during a spark and hence increase the STOC amplitude, if it were not already maximal at that voltage. To test the effects of forskolin on KCa channels, single-channel currents through KCa channels were recorded from isolated arterial myocytes in the whole cell mode, using the perforated-patch technique. Single KCa channels were identified by their characteristic large single-channel conductance, voltage dependence, and sensitivity to block by tetraethylamonium and iberiotoxin (7, 23, 28, 31).
Forskolin increased single KCa channel activity (measured as NPo) from 0.041 ± 0.015 to 0.055 ± 0.02 (n = 7) measured over 5 min at 0 mV (Fig. 4). The single-channel current amplitude was not affected by forskolin (at 0 mV: control, 5.0 ± 0.2 pA; forskolin, 5.0 ± 0.2 pA, n = 7). The forskolin-induced increase in NPo did not appear to be the result of an elevation in global Ca2+ in these voltage-clamped cells, since Ca2+ measured with fura 2 did not increase (106.0 ± 5.4% of the control, n = 4). Forskolin would not be expected to decrease average Ca2+ under these conditions, since the voltage of the cells was controlled. These results are consistent with the idea that forskolin increased NPo by 1.3-fold through an effect of cAMP/PKA directly on the KCa channel and thus provide an explanation for the increase in STOC amplitude to forskolin.
|
Role of Ca2+
sparks and KCa channels in forskolin-induced
dilations.
We tested the hypothesis that part of the forskolin dilation of
pressurized cerebral arteries is through increasing
Ca2+ spark frequency, activating
KCa channels. Consistent with this hypothesis, an inhibitor of Ca2+
sparks, ryanodine, inhibited 79.8 ± 8.1% of the forskolin-induced dilation of pressurized cerebral arteries with tone (Fig.
5D). Furthermore, ryanodine constricted pressurized cerebral arteries to a
similar diameter in the absence (to 81 ± 7 µm) (28) or presence
of forskolin (100 nM; to 85 ± 20 µm,
n = 5), consistent with forskolin
acting on a ryanodine-sensitive process. The blocker of
KCa channels, iberiotoxin, also
inhibited 82.3 ± 7.0% of the forskolin-induced dilation (Fig.
5D) (as shown
previously, see Ref. 42). The effects of ryanodine and iberiotoxin were
not additive (Fig. 5, B and
D; see also Ref. 28), consistent with the idea that Ca2+ sparks act to
stimulate KCa channels (28). Part
of the dilation to forskolin was insensitive to iberiotoxin or
ryanodine, particularly at higher forskolin concentrations, suggesting
that forskolin also acts through other mechanisms (1, 11, 15, 18, 19, 36, 41, 48). In this preparation, however, forskolin (10 µM or less)
was ineffective on pressurized arteries that were constricted with high
(60 mM) K+ (Fig. 5,
A and
D), consistent with forskolin acting
in large part through activation of
K+ channels (1, 31). Ryanodine and
iberiotoxin were ineffective on pressurized arteries previously dilated
with the Ca2+ channel blocker
diltiazem (1 µM; Fig. 5C), a
condition that would lower Ca2+
spark frequency and hence KCa
channel activity (7, 20, 28, 31) through reducing average intracellular
Ca2+ and SR
Ca2+ content. These results
suggest that forskolin dilates pressurized cerebral arteries through
activation of K+ channels, with
part of the dilation due to activation of the Ca2+
spark
KCa channel pathway.
|
| |
DISCUSSION |
|---|
|
|
|---|
The present study proposes a new mechanism of action for vasodilators that work through cAMP and cGMP (Fig. 7). Our data suggest that cAMP and cGMP can increase KCa channel activity in two ways: 1) by increasing Ca2+ spark frequency and 2) by directly increasing the open probability of the KCa channel. Together these actions lead to increased frequency and amplitude of STOCs, which, when summed across the vessel wall, should cause membrane potential hyperpolarization and, ultimately, relaxation of the artery.
|
|
Comparison of Ca2+ spark and STOC frequency. The mean Ca2+ spark frequency (0.14 Hz) was ~15% of the mean STOC frequency (0.96 Hz). We estimate that we could detect Ca2+ sparks in no more than 23% of cell volume, based on the average spread of a Ca2+ spark (4.8 µm) and maximum width of a cell (10 µm) (28) (assuming a circular cross section of a cell). This detection volume would be less when a scan line is close to the side of the cell and when the length of the scan line is less than the length of the cell, which is the case when the cells are not straight. These results are consistent with the idea that most Ca2+ sparks cause STOCs (17).
Effects on Ca2+ sparks. Forskolin, SNP, and nicorandil increased Ca2+ spark frequency. Forskolin, through cAMP/PKA, could act directly on the RyR channel (43, 46) and/or indirectly through an elevation of SR Ca2+ load, which has been shown to increase the open state probability of RyR channels in skeletal and cardiac muscle (12, 26, 45, 46). cAMP/PKA and cGMP/PKG could increase SR Ca2+ load by enhancing SR Ca2+-ATPase activity by phosphorylating phospholamban (25). The observed increase in caffeine-induced Ca2+ transients in the presence of forskolin (Fig. 6) is consistent with cAMP/PKA increasing SR Ca2+ load. However, forskolin did not cause a detectable increase in Ca2+ spark amplitude, which could be indicative of SR Ca2+ load. Nicorandil did increase Ca2+ spark amplitude by ~10%. Our data do not distinguish between a direct effect on ryanodine receptors and an indirect effect of SR Ca2+ load on Ca2+ spark frequency. cAMP (PKA) and cGMP (PKG) could conceivably act on both the Ca2+-ATPase and the RyR channel to affect SR function and STOC frequency (see Fig. 7) (49).
Contribution of STOCs to overall KCa channel activity. KCa channels do not appear to contribute significantly to regulation of smooth muscle membrane potential in intact pressurized cerebral arteries when Ca2+ sparks are blocked (28). This suggestion is based on the observation that blockers of KCa channels (iberiotoxin) were without effect on pressurized cerebral arteries when inhibitors of Ca2+ sparks (ryanodine, thapsigargin, or cyclopiazonic acid) were present. Furthermore, iberiotoxin was without effect in the presence of ryanodine and forskolin (Fig. 5B), suggesting that, even in the presence of forskolin, KCa channels do not contribute significantly to the regulation of arterial diameter without Ca2+ sparks.
The relative activity (NPo) of KCa channels with and without Ca2+ sparks can be estimated from the data presented here and from Ref. 28. At
40 to
30 mV,
NPo contributed
by Ca2+ sparks is ~0.4 (assuming
peak NPo = 13 lasting 30 ms, frequency 1/s). Baseline
NPo is estimated
to be in the range of 0.01 at physiological membrane potentials and
Ca2+ in pressurized arteries
(
40 mV, 200 nM Ca2+),
based on extrapolation from direct measurements (Fig. 4). Assuming a
slope conductance of KCa channels
of 79 pS (estimate at
30 to
40 mV from current-voltage
relationship), this would correspond to an average
KCa channel conductance of ~32
pS with sparks, consistent with a significant contribution to membrane
conductance of smooth muscle cells with a 10 G
input resistance (see
Ref. 31). However, <5% of the
KCa channel conductance would be
contributed by channels not activated by
Ca2+ sparks. Forskolin would
increase NPo
caused by sparks two- to threefold or from 0.4 to
0.8-1.2. However, forskolin would directly increase
NPo in the
absence of sparks by 1.3 or to ~0.013-0.026. Regardless of the
uncertainties, these estimates support the idea that
Ca2+ sparks should have a profound
impact on the overall activity of
KCa channels and that forskolin
acts largely (99%) on KCa
channels through increasing Ca2+
spark frequency.
Proposed mechanism for regulation of arterial diameter by cAMP/PKA or by cGMP/PKG via Ca2+ sparks and KCa channels. Elevation of intravascular pressure causes a graded membrane potential depolarization and vasoconstriction of small myogenic arteries (Fig. 7) (7, 20, 27, 31). The membrane potential depolarization increases the steady-state open probability of voltage-dependent Ca2+ channels (30, 40), which elevates Ca2+ entry and global intracellular Ca2+ (21, 27). Ca2+ channel inhibitors (e.g., nimodipine, diltiazem) prevent pressure-induced constrictions of myogenic cerebral arteries (7, 20, 30). Intracellular Ca2+ could increase Ca2+ spark frequency through cytoplasmic and SR luminal activation of RyR channels. Ca2+ sparks, by themselves, would have little direct effect on intracellular Ca2+, even at the highest observed rate (4/s) (28). Ca2+ sparks would, however, have a profound effect on the activity of KCa channels, which would oppose the pressure-induced membrane potential depolarization. In support of this proposed mechanism, blockers of KCa channels (e.g., iberiotoxin) and Ca2+ sparks (ryanodine, cyclopiazonic acid, thapsigargin) depolarize and constrict pressurized (60 mmHg) myogenic cerebral arteries by ~8 mV and 30% (7, 20, 28). Lowering intravascular pressure (7) or blocking Ca2+ channels (7, 20, 28), which would decrease intracellular Ca2+ and thus KCa channel activity, abolished the effects of iberiotoxin and ryanodine on membrane potential and arterial diameter (also see Fig. 6B with diltiazem). Furthermore, iberiotoxin was without effect on membrane potential and diameter in intact pressurized arteries, when Ca2+ sparks were blocked by ryanodine or thapsigargin (28) (see also Fig. 6A), suggesting that global intracellular Ca2+ does not cause sufficient activation of KCa channels to modulate membrane potential (see above).
Iberiotoxin blocks a significant fraction of the dilation of rat cerebral arteries to forskolin (see Fig. 5 and Ref. 42). However, high extracellular K+ blocked the entire dilation to forskolin. cAMP/PKA has also been shown to activate ATP-sensitive K+ (KATP) channels (18, 19, 36, 48) and voltage-dependent K+ channels (1) in smooth muscle. Forskolin dilations of cerebral arteries were not affected by glibenclamide, an inhibitor of KATP channels (data not shown; also observed in Ref. 42), suggesting that KATP channels do not contribute to the observed dilations. Voltage-dependent K+ channels contribute significantly to the regulation of the membrane potential and diameter of pressurized cerebral arteries (20), suggesting the possibility that forskolin acts in part on this channel (cf. Ref. 1). These results indicate that the forskolin response in our preparation is entirely mediated by effects on the K+ conductance of the cell and that part of this change in K+ conductance is due to effects on the KCa channel. Here we demonstrate that agents that elevate cGMP (SNP and nicorandil) increase Ca2+ spark and STOC frequency, as well as increase STOC amplitude in coronary arteries from rat. In the same intact coronary artery preparation, SNP (10 µM) has been shown to cause a 13-mV hyperpolarization and almost maximal dilation, which was substantially blocked by iberiotoxin (47). PKG has also been shown to activate KCa channels in excised patches from the same coronary artery myocytes (Ref. 47; see also Refs. 39 and 44). cGMP/PKG can increase SR Ca2+ uptake, presumably through an action on phospholamban (10). Furthermore, smooth muscle relaxations to nitrovasodilators in mesenteric (8, 16), pulmonary (3), and cerebral arteries (33) can be partially inhibited by iberiotoxin, suggesting a role for KCa channels in relaxations of a number of types of vascular smooth muscle to cGMP. These results support the general mechanism presented in Fig. 7 (see also Fig. 4 in Ref. 28). In conclusion, the present study proposes a new mechanism of action for vasodilators that work through cAMP and cGMP in cerebral and coronary arteries (Fig. 7). Our data indicate that cAMP and cGMP can increase Ca2+ spark frequency two- to threefold as well as have a small, direct effect on KCa channel open probability (23, 39, 44). Together these actions lead to increased frequency and amplitude of STOCs, which, when summed across the vessel wall, should cause membrane potential hyperpolarization and, ultimately, relaxation of the artery through decreasing Ca2+ entry through voltage-dependent Ca2+ channels (7, 28, 31), thereby lowering arterial wall Ca2+ (Fig. 6). The frequency of Ca2+ sparks, even with elevated cAMP or cGMP (2-3 sparks · s
1 · cell
1),
would have little direct effect on average cytoplasmic
Ca2+. Our results would then
explain with one integrated mechanism (Fig. 7) the apparently disparate
observations that cAMP and cGMP can increase SR
Ca2+ uptake and lower arterial
Ca2+, and, yet, relaxations to
these cyclic nucleotides are often inhibited by blockers of
KCa channels (16, 33, 35, 42). This mechanism (frequency modulation of
Ca2+ sparks), along with
activation of KATP channels and
voltage-dependent K+ channels,
inhibition of Ca2+ channels, and
changes in Ca2+ sensitivity, would
contribute to the actions of cAMP and cGMP. We suggest that frequency
modulation of Ca2+ sparks by
cAMP/cGMP may be a general mechanism for the SR to regulate
plasmalemmal Ca2+ entry through
alterations in a cell's membrane potential.
| |
ACKNOWLEDGEMENTS |
|---|
We thank the late Dr. Fred Fay and Dr. John Walsh for insights and comments on this study.
| |
FOOTNOTES |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grants HL-44455, HL-51728, and HL-58231, National Science Foundation Grant IBN-9631416, a grant from the Alexander Von Humboldt Foundation (to T. Kleppisch), and a fellowship (to V. A. Porter) from the American Heart Association, New Hampshire and Vermont Affiliates.
Address for reprint requests: M. T. Nelson, Dept. of Pharmacology, 55A South Park Dr., Univ. of Vermont, Colchester, VT 05446.
Received 9 September 1997; accepted in final form 13 January 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Aiello, E. A.,
M. P. Walsh,
and
W. C. Cole.
Phosphorylation by protein kinase A enhances delayed rectifier K+ current in rabbit vascular smooth muscle cells.
Am. J. Physiol.
268 (Heart Circ. Physiol. 37):
H926-H934,
1995
2.
Anwer, K.,
C. Oberti,
G. J. Perez,
N. Perez-Reyes,
J. K. McDougall,
M. Monga,
B. M. Sanborn,
E. Stefani,
and
L. Toro.
Calcium-activated K+ channels as modulators of human myometrial contractile activity.
Am. J. Physiol.
265 (Cell Physiol. 34):
C976-C985,
1993
3.
Archer, S. L.,
J. M. Huang,
V. Hampl,
D. P. Nelson,
P. J. Shultz,
and
E. K. Weir.
Nitric oxide and cGMP cause vasodilation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase.
Proc. Natl. Acad. Sci. USA
91:
7583-7587,
1994
4.
Benham, C. D.,
and
T. B. Bolton.
Spontaneous transient outward currents in single visceral and vascular smooth muscle cells of the rabbit.
J. Physiol. (Lond.)
381:
385-406,
1986
5.
Berridge, M. J.
The AM and FM of calcium signalling.
Nature
386:
759-760,
1997[Medline].
6.
Berridge, M. J.
Elementary and global aspects of calcium signalling.
J. Physiol. (Lond.)
499:
291-306,
1997[Medline].
7.
Brayden, J. E.,
and
M. T. Nelson.
Regulation of arterial tone by activation of calcium-dependent potassium channels.
Science
256:
532-535,
1992
8.
Carrier, G. O.,
L. C. Fuchs,
A. P. Winecoff,
A. D. Giulumian,
and
R. E. White.
Nitrovasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels.
Am. J. Physiol.
273 (Heart Circ. Physiol. 42):
H76-H84,
1997
9.
Clapp, L. H.,
and
A. M. Gurney.
Modulation of calcium movements by nitroprusside in isolated vascular smooth muscle cells.
Pflügers Arch.
418:
462-470,
1991[Medline].
10.
Cornwell, T. L.,
K. B. Pryzwansky,
T. A. Wyatt,
and
T. M. Lincoln.
Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells.
Mol. Pharmacol.
40:
923-931,
1991[Abstract].
11.
DeLanerolle, P.,
M. Nikishikawa,
D. A. Yost,
and
R. S. Adelstein.
Increased phosphorylation of myosin light chain kinase after an increase in cyclic AMP in intact smooth muscle.
Science
223:
1415-1417,
1984
12.
Gilchrist, J. S.,
A. N. Belcastro,
and
S. Katz.
Intraluminal Ca2+ dependence of Ca2+ and ryanodine-mediated regulation of skeletal muscle sarcoplasmic reticulum Ca2+ release.
J. Biol. Chem.
267:
20850-20856,
1992
13.
Hamill, O. P.,
A. Marty,
B. Neher,
B. Sakmann,
and
F. J. Sigworth.
Improved patch-clamp techniques for high-resolution current recording from cells and cell free membrane patches.
Pflügers Arch.
391:
85-100,
1981[Medline].
14.
Horn, R.,
and
A. Marty.
Muscarinic activation of ionic currents measured by a new whole-cell recording method.
J. Gen. Physiol.
92:
145-159,
1988
15.
Kerrick, W. G.,
and
P. E. Hoar.
Inhibition of smooth muscle tension by cyclic AMP-dependent protein kinase.
Nature
292:
253-255,
1981[Medline].
16.
Khan, S. A.,
W. R. Mathews,
and
K. D. Meisheri.
Role of calcium-activated K+ channels in vasodilation induced by nitroglycerine, acetylcholine and nitric oxide
J. Pharmacol. Exp. Ther.
267:
1327-1335,
1993
17.
Kirber, M. T.,
E. F. Etter,
J. J. Singer,
J. V. Walsh,
and
F. S. Fay.
Simultaneous 3D imaging of Ca2+ sparks and ionic currents in single smooth muscle cells (Abstract).
Biophys. J.
72:
A295,
1997.
18.
Kleppisch, T.,
and
M. T. Nelson.
ATP-sensitive K+ currents in cerebral arterial smooth muscle: pharmacological and hormonal modulation.
Am. J. Physiol.
269 (Heart Circ. Physiol. 38):
H1634-H1640,
1995
19.
Kleppisch, T.,
and
M. T. Nelson.
Adenosine activates ATP-sensitive potassium channels in arterial myocytes via A2 receptors and cAMP-dependent protein kinase.
Proc. Natl. Acad. Sci. USA
92:
12441-12445,
1995
20.
Knot, H. J.,
and
M. T. Nelson.
Regulation of membrane potential and diameter by voltage-dependent K+ channels in rabbit myogenic cerebral arteries.
Am. J. Physiol.
269 (Heart Circ. Physiol. 38):
H348-H355,
1995
21.
Knot, H. J., N. B. Standen, and M. T. Nelson. Ryanodine receptors regulate arterial diameter and
wall [Ca2+] in
cerebral arteries of rat via KCa channels.
J. Physiol. (Lond.) In press.
22.
Komori, S.,
and
T. B. Bolton.
Actions of guanine nucleotides and cyclic nucleotides on calcium stores in single patch-clamped smooth muscle cells from rabbit portal vein.
Br. J. Pharmacol.
97:
973-982,
1989[Medline].
23.
Kotlikoff, M. I.,
and
K. E. Kamm.
Molecular mechanisms of
-adrenergic relaxation of airway smooth muscle.
Annu. Rev. Physiol.
58:
115-141,
1996[Medline].
24.
Lincoln, T. M.,
and
T. L. Cornwell.
Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation.
Blood Vessels
28:
129-137,
1991[Medline].
25.
Linderman, J. P.,
L. R. Jones,
D. R. Hathaway,
B. G. Henry,
and
A. M. Watanabe.
-Adrenergic stimulation of phospholamban phosphorylation and Ca2+ ATPase activation in guinea pig ventricle.
J. Biol. Chem.
258:
464-471,
1983
26.
Lukyanenko, V.,
I. Gyorke,
and
S. Gyorke.
Regulation of calcium release by calcium inside the sarcoplasmic reticulum in ventricular myocytes.
Pflügers Arch.
432:
1047-1054,
1996[Medline].
27.
Meininger, G. A.,
and
M. J. Davis.
Cellular mechanisms involved in vascular myogenic response.
Am. J. Physiol.
263 (Heart Circ. Physiol. 32):
H647-H659,
1992
28.
Nelson, M. T.,
H. Cheng,
M. Rubart,
L. F. Santana,
A. D. Bonev,
H. J. Knot,
and
W. J. Lederer.
Relaxation of arterial smooth muscle by calcium sparks.
Science
270:
633-637,
1995
29.
Nelson, M. T.,
Y. Huang,
J. E. Brayden,
J. Hescheler,
and
N. B. Standen.
Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels.
Nature
344:
770-773,
1990[Medline].
30.
Nelson, M. T.,
J. B. Patlak,
J. F. Worley,
and
N. B. Standen.
Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone.
Am. J. Physiol.
259 (Cell Physiol. 28):
C3-C18,
1990
31.
Nelson, M. T.,
and
J. M. Quayle.
Physiological roles and properties of potassium channels in arterial smooth muscle.
Am. J. Physiol.
268 (Cell Physiol. 37):
C799-C822,
1995
32.
Onoue, H.,
and
Z. S. Katusic.
Role of potassium channels in relaxations of canine middle cerebral arteries induced by nitric oxide donors.
Stroke
28:
1264-1270,
1997
33.
Paterno, R.,
F. M. Faraci,
and
D. D. Heistad.
Role of Ca2+-dependent K+ channels in cerebral vasodilation induced by increases in cyclic GMP and cyclic AMP in the rat.
Stroke
27:
1503-1607,
1996.
34.
Pessah, I. N.,
R. A. Stambuk,
and
J. E. Casida.
Ca2+-activated ryanodine binding: mechanisms of sensitivity and intensity modulation by Mg2+, caffeine and adenine nucleotides.
Mol. Pharmacol.
31:
232-238,
1987[Abstract].
35.
Price, J. M.,
J. F. Cabell,
and
A. Hellermann.
Inhibition of cAMP mediated relaxation in rat coronary vessels by block of Ca2+ activated K+ channels.
Life Sci.
58:
2225-2232,
1996[Medline].
36.
Quayle, J. M.,
A. D. Bonev,
J. E. Brayden,
and
M. T. Nelson.
Calcitonin gene-related peptide activated ATP-sensitive K+ currents in rabbit arterial smooth muscle via protein kinase A.
J. Physiol. (Lond.)
475:
9-13,
1994
37.
Quayle, J. M.,
J. R. McCarron,
J. R. Asbury,
and
M. T. Nelson.
Single calcium channels in resistance-sized cerebral arteries from rats.
Am. J. Physiol.
264 (Heart Circ. Physiol. 33):
H470-H478,
1993
38.
Robertson, B. E.,
A. D. Bonev,
and
M. T. Nelson.
Inward rectifier K+ currents in smooth muscle cells from rat coronary arteries: block by Mg2+, Ca2+, and Ba2+.
Am. J. Physiol.
271 (Heart Circ. Physiol. 40):
H696-H705,
1996
39.
Robertson, B. E.,
R. Schubert,
J. Hescheler,
and
M. T. Nelson.
cGMP-dependent protein kinase activates Ca-activated K+ channels in cerebral artery smooth muscle cells.
Am. J. Physiol.
265 (Cell Physiol. 34):
C299-C303,
1993
40.
Rubart, M.,
J. B. Patlak,
and
M. T. Nelson.
Ca2+ currents in cerebral artery smooth muscle cells of rat at physiological Ca2+ concentrations.
J. Gen. Physiol.
107:
459-472,
1996
41.
Somlyo, A. P.,
and
A. V. Somlyo.
Signal transduction and regulation in smooth muscle.
Nature
372:
231-236,
1994[Medline].
42.
Taguchi, H.,
D. D. Heistad,
T. Kitazano,
and
F. M. Faraci.
Dilatation of cerebral arterioles in response to activation of adenylate cyclase is dependent on activation of Ca2+-dependent K+ channels.
Circ. Res.
76:
1057-1062,
1995
43.
Takasago, T.,
T. Imagawa,
and
M. Shigekawa.
Phosphorylation of the cardiac ryanodine receptor by cAMP-dependent protein kinase.
J. Biochem. (Tokyo)
106:
872-877,
1989
44.
Taniguchi, J.,
K. I. Furukawa,
and
M. Shigekawa.
Maxi K+ channels are stimulated by cyclic guanosine monophosphate-dependent protein kinase in canine coronary artery smooth muscle cells.
Pflügers Arch.
423:
167-172,
1993[Medline].
45.
Tripathy, A.,
and
G. Meissner.
Sarcoplasmic reticulum lumenal Ca2+ has access to cytosolic activation and inactivation sites of skeletal muscle Ca2+ release channel.
Biophys. J.
70:
2600-2615,
1996
46.
Valdivia, H. H.,
J. H. Kaplan,
G. C. Ellis-Davies,
and
W. J. Lederer.
Rapid adaptation of cardiac ryanodine receptors: modulation by Mg2+ and phosphorylation.
Science
267:
1997-2000,
1995
47.
Wellman, G. C.,
A. D. Bonev,
M. T. Nelson,
and
J. E. Brayden.
Gender differences in coronary artery diameter involve estrogen, nitric oxide, and Ca2+-dependent K+ channels.
Circ. Res.
79:
1024-1030,
1996
48.
Zhang, L.,
A. D. Bonev,
G. M. Mawe,
and
M. T. Nelson.
Protein kinase A mediates activation of ATP-sensitive K+ currents by CGRP in gallbladder smooth muscle.
Am. J. Physiol.
267 (Gastrointest. Liver Physiol. 30):
G494-G499,
1994
49.
ZhuGe, R.,
and
F. S. Fay.
Luminal Ca2+ determines spontaneous transient outward currents in stomach muscle cells from Bufo marinus (Abstract).
Biophys. J.
72:
A185,
1997.
This article has been cited by other articles:
![]() |
M. Kim, G. W. Hennig, K. Park, I. S. Han, T. K. Smith, S. D. Koh, and B. A. Perrino Modulation of murine gastric antrum smooth muscle STOC activity and excitability by phospholamban J. Physiol., October 15, 2008; 586(20): 4977 - 4991. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Werner, A. L. Meredith, R. W. Aldrich, and M. T. Nelson Hypercontractility and impaired sildenafil relaxations in the BKCa channel deletion model of erectile dysfunction Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R181 - R188. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Blanco, J. E. Stern, and J. A. Filosa Tone-dependent vascular responses to astrocyte-derived signals Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2855 - H2863. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhang, H. H. Patel, F. Murray, C. V. Remillard, C. Schach, P. A. Thistlethwaite, Paul. A. Insel, and J. X.-J. Yuan Pulmonary artery smooth muscle cells from normal subjects and IPAH patients show divergent cAMP-mediated effects on TRPC expression and capacitative Ca2+ entry Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1202 - L1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kim and B. A. Perrino CaM kinase II activation and phospholamban phosphorylation by SNP in murine gastric antrum smooth muscles Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1045 - G1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hayoz, J.-L. Beny, and R. Bychkov Intracellular cAMP: the "switch" that triggers on "spontaneous transient outward currents" generation in freshly isolated myocytes from thoracic aorta Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1502 - C1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kim, I. S. Han, S. D. Koh, and B. A. Perrino Roles of CaM kinase II and phospholamban in SNP-induced relaxation of murine gastric fundus smooth muscles Am J Physiol Cell Physiol, August 1, 2006; 291(2): C337 - C347. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Hagen, O. Bayguinov, and K. M. Sanders VIP and PACAP regulate localized Ca2+ transients via cAMP-dependent mechanism Am J Physiol Cell Physiol, August 1, 2006; 291(2): C375 - C385. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cheng and J. H. Jaggar Genetic ablation of caveolin-1 modifies Ca2+ spark coupling in murine arterial smooth muscle cells Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2309 - H2319. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Burnham, I. T. Johnson, and A. H. Weston Reduced Ca2+-dependent activation of large-conductance Ca2+-activated K+ channels from arteries of Type 2 diabetic Zucker diabetic fatty rats Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1520 - H1527. [Abstract] [Full Text] [PDF] |
||||
![]() |